TrumpRx Drug Discounts Fall Short of Promises, According to KFF Report
A new study shows that drug discounts offered through TrumpRx present a mixed picture and do not always deliver on the promise of the world's lowest prices.
A comprehensive analysis conducted by KFF revealed that the world's lowest prescription drug prices promised by Donald Trump are not consistently delivered through TrumpRx discounts.
Details of TrumpRx Discounts
According to the KFF analysis, drug discounts offered through TrumpRx exhibit a highly variable structure, and the promised savings are not achieved for certain medications.
International Price Comparisons
As part of the research, TrumpRx prices were compared with prices in eleven developed countries, including Canada, France, Germany, the Netherlands, and the United Kingdom.
Examples of Ozempic and Enbrel
TrumpRx prices for popular medications such as Ozempic and Enbrel remain well above the average prices in other wealthy nations.
Some Medications Appear Advantageous
For certain specific medications, such as Rydapt used in the treatment of blood cancer, TrumpRx prices are lower compared to other countries.
General Results of the Research
Out of the thirty-two brand-name drugs examined, seventeen had prices lower than foreign averages, while fifteen showed higher prices.
Promise of the Lowest Price
According to the analysis results, only five of the examined drugs actually fell into the lowest-priced category, while thirteen were recorded as the highest-priced.